Formats
  1. Journal Article (67268)
  2. Meeting Abstract (33961)
  3. Book Section (5131)
  4. Review (3869)
  5. Editorial (2247)
  6. Conference Paper (1528)
  7. Guidelines (686)
  8. Correspondence (679)
  9. Research Letter (565)
  10. Book Whole (346)
  11. Miscellaneous (344)
Groups
  1. Department of Medicine (39471)
  2. GSK Faculty (22633)
  3. Solid Tumor Oncology Division (22265)
  4. Surgery (21423)
  5. Survivorship Research (15906)
  6. Sloan Kettering Institute Faculty (15715)

More Groups

People
  1. Marc Ladanyi (1332)
  2. Robert Motzer (1247)
  3. Victor Reuter (1230)
  4. Howard Scher (1130)
  5. Sergio Giralt (1065)
  6. Murray Brennan (1059)

More People

Years
  1. 2026 (7)
  2. 2025 (2927)
  3. 2024 (5602)
  4. 2023 (5809)
  5. 2022 (6169)
  6. 2021 (5720)

More Years

Publications
  1. Journal of Clinical Oncology (8694)
  2. Blood (5173)
  3. Cancer Research (2703)
  4. International Journal of Radiation Oncology, Biology, Physics (2621)
  5. Laboratory Investigation (1890)
  6. Modern Pathology (1817)

More Publications

Publishers
  1. Elsevier Inc. (13955)
  2. American Society of Clinical Oncology (9291)
  3. Springer (7231)
  4. Nature Publishing Group (6443)
  5. American Association for Cancer Research (6026)
  6. Elsevier Science, Inc. (5556)

More Publishers

Results (116624)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • APR-246 enhances tumor immunogenicity even in the absence of p53
    Meeting Abstract

    Venkatesh, D.; Michels, J.; Liu, C.; Budhu, S.; George, M. M.; Abrahmsen, L.; Zappasodi, R.; Wolchok, J. D.; Merghoub, T.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Interrogating chromosomal instability in the earliest steps of ovarian cancer development
    Meeting Abstract

    Al-Rawi, D. H.; Chui, H.; Shah, S.; Bakhoum, S.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Epigenetic control of tumor cell killing by natural killer cells
    Meeting Abstract

    Pasion, J.; Barisic, D.; Meydan, C.; Ng, K. Y.; Lafoz, M. T.; Huse, M.; Melnick, A.; Wendel, H. G.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • DeepTumour: Identify tumor origin from whole genome sequences
    Meeting Abstract

    Stein, L. D.; Jiao, W.; Atwal, G.; Morris, Q.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Prediction of neoadjuvant treatment outcomes with multimodal data integration in breast cancer
    Meeting Abstract

    Khosravi, P.; Sutton, E. J.; Jee, J.; Dalfonso, T.; Fong, C. J.; Rose, D.; Da Silva, E. M.; Kohli, A.; Ho, D. J.; Ahmed, M. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Enabling single cell analysis of copy number variation in breast cancer
    Meeting Abstract

    Parikh, S.; Paula, A. D.; Bhaloo, S. I.; Li, A.; Weigelt, B.; Patel, K.; Wronski, A.; Parikh, A.; Patel, K.; Reis, J.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Splicing factor mutant lung cancers: A comprehensive molecular and clinicopathologic characterization
    Meeting Abstract

    Harada, G.; Falcon, C. J.; Santini, F. C.; Chang, J. C.; Yang, S. R.; Arcila, M. E.; Rekhtman, N.; Drilon, A.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • MEKi-FGFRi combination nanoparticles for use against KRAS(mt)/FGFR-compensatory lung tumors
    Meeting Abstract

    Izawa-Ishiguro, A. R.; Sridharan, R.; Wun, C.; Sami, T. J.; Heller, D. A.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Identifying molecular drivers of olaparib resistance through genome-wide sgRNA screening in prostate organoids
    Meeting Abstract

    Pappas, K. J.; Karthaus, W.; Laclair, J.; Russo, M.; Sawyers, C.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • MSK-ACCESS Heme: A cell-free DNA next-generation sequencing assay to identify somatic alterations in patients with lymphoma
    Meeting Abstract

    DiNapoli, S. E.; Spence, C.; Gedvilaite, E.; Bowman, A.; Diosdado, M.; Razumova, A.; Tsui, D.; Salles, G. A.; Batlevi, C.; von Keudell, G.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save